nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP2D6—Hydroxyurea—head and neck cancer	0.355	0.449	CbGbCtD
Palonosetron—CYP1A2—Fluorouracil—head and neck cancer	0.165	0.208	CbGbCtD
Palonosetron—CYP2D6—Vinblastine—head and neck cancer	0.126	0.159	CbGbCtD
Palonosetron—CYP3A4—Vinblastine—head and neck cancer	0.08	0.101	CbGbCtD
Palonosetron—CYP3A4—Docetaxel—head and neck cancer	0.0659	0.0832	CbGbCtD
Palonosetron—Platelet count decreased—Hydroxyurea—head and neck cancer	0.00716	0.0344	CcSEcCtD
Palonosetron—Sinus tachycardia—Docetaxel—head and neck cancer	0.00549	0.0264	CcSEcCtD
Palonosetron—Prurigo—Docetaxel—head and neck cancer	0.00479	0.023	CcSEcCtD
Palonosetron—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.0045	0.0216	CcSEcCtD
Palonosetron—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00381	0.0183	CcSEcCtD
Palonosetron—Eye irritation—Fluorouracil—head and neck cancer	0.00359	0.0172	CcSEcCtD
Palonosetron—Dermatitis atopic—Docetaxel—head and neck cancer	0.00299	0.0144	CcSEcCtD
Palonosetron—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00275	0.0132	CcSEcCtD
Palonosetron—Euphoric mood—Fluorouracil—head and neck cancer	0.00263	0.0127	CcSEcCtD
Palonosetron—Eye irritation—Docetaxel—head and neck cancer	0.00259	0.0124	CcSEcCtD
Palonosetron—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00243	0.0117	CcSEcCtD
Palonosetron—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00225	0.0108	CcSEcCtD
Palonosetron—Respiratory failure—Docetaxel—head and neck cancer	0.00225	0.0108	CcSEcCtD
Palonosetron—Injection site reaction—Docetaxel—head and neck cancer	0.0022	0.0106	CcSEcCtD
Palonosetron—Influenza like illness—Docetaxel—head and neck cancer	0.00215	0.0103	CcSEcCtD
Palonosetron—Fluid retention—Docetaxel—head and neck cancer	0.0021	0.0101	CcSEcCtD
Palonosetron—Alopecia—Vinblastine—head and neck cancer	0.00207	0.00996	CcSEcCtD
Palonosetron—Angiopathy—Hydroxyurea—head and neck cancer	0.00194	0.00932	CcSEcCtD
Palonosetron—Chills—Hydroxyurea—head and neck cancer	0.00192	0.00922	CcSEcCtD
Palonosetron—Alopecia—Hydroxyurea—head and neck cancer	0.00189	0.00908	CcSEcCtD
Palonosetron—Anaemia—Vinblastine—head and neck cancer	0.00189	0.00907	CcSEcCtD
Palonosetron—Erythema—Hydroxyurea—head and neck cancer	0.00186	0.00895	CcSEcCtD
Palonosetron—Convulsion—Vinblastine—head and neck cancer	0.00177	0.0085	CcSEcCtD
Palonosetron—Hypertension—Vinblastine—head and neck cancer	0.00176	0.00847	CcSEcCtD
Palonosetron—Anaemia—Hydroxyurea—head and neck cancer	0.00172	0.00827	CcSEcCtD
Palonosetron—Discomfort—Vinblastine—head and neck cancer	0.00172	0.00825	CcSEcCtD
Palonosetron—Hot flush—Docetaxel—head and neck cancer	0.00172	0.00825	CcSEcCtD
Palonosetron—Menopausal symptoms—Docetaxel—head and neck cancer	0.0017	0.00818	CcSEcCtD
Palonosetron—Epistaxis—Fluorouracil—head and neck cancer	0.00162	0.00777	CcSEcCtD
Palonosetron—Convulsion—Hydroxyurea—head and neck cancer	0.00161	0.00775	CcSEcCtD
Palonosetron—Sinusitis—Fluorouracil—head and neck cancer	0.00161	0.00773	CcSEcCtD
Palonosetron—Pain in extremity—Docetaxel—head and neck cancer	0.00161	0.00772	CcSEcCtD
Palonosetron—Anorexia—Vinblastine—head and neck cancer	0.00159	0.00763	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00157	0.00756	CcSEcCtD
Palonosetron—Discomfort—Hydroxyurea—head and neck cancer	0.00157	0.00752	CcSEcCtD
Palonosetron—Infection—Hydroxyurea—head and neck cancer	0.00151	0.00725	CcSEcCtD
Palonosetron—Paraesthesia—Vinblastine—head and neck cancer	0.0015	0.00719	CcSEcCtD
Palonosetron—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00149	0.00716	CcSEcCtD
Palonosetron—Skin disorder—Hydroxyurea—head and neck cancer	0.00148	0.00709	CcSEcCtD
Palonosetron—Abdominal pain upper—Docetaxel—head and neck cancer	0.00147	0.00705	CcSEcCtD
Palonosetron—Anorexia—Hydroxyurea—head and neck cancer	0.00145	0.00696	CcSEcCtD
Palonosetron—Decreased appetite—Vinblastine—head and neck cancer	0.00145	0.00696	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00145	0.00695	CcSEcCtD
Palonosetron—Constipation—Vinblastine—head and neck cancer	0.00142	0.00685	CcSEcCtD
Palonosetron—Pain—Vinblastine—head and neck cancer	0.00142	0.00685	CcSEcCtD
Palonosetron—Arrhythmia—Fluorouracil—head and neck cancer	0.00137	0.00661	CcSEcCtD
Palonosetron—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00136	0.00655	CcSEcCtD
Palonosetron—Alopecia—Fluorouracil—head and neck cancer	0.00136	0.00654	CcSEcCtD
Palonosetron—Dyspnoea—Hydroxyurea—head and neck cancer	0.00135	0.00651	CcSEcCtD
Palonosetron—Somnolence—Hydroxyurea—head and neck cancer	0.00135	0.00649	CcSEcCtD
Palonosetron—Erythema—Fluorouracil—head and neck cancer	0.00134	0.00644	CcSEcCtD
Palonosetron—Dyspepsia—Hydroxyurea—head and neck cancer	0.00134	0.00643	CcSEcCtD
Palonosetron—Decreased appetite—Hydroxyurea—head and neck cancer	0.00132	0.00635	CcSEcCtD
Palonosetron—Abdominal pain—Vinblastine—head and neck cancer	0.00132	0.00633	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00131	0.0063	CcSEcCtD
Palonosetron—Fatigue—Hydroxyurea—head and neck cancer	0.00131	0.00629	CcSEcCtD
Palonosetron—Pain—Hydroxyurea—head and neck cancer	0.0013	0.00624	CcSEcCtD
Palonosetron—Constipation—Hydroxyurea—head and neck cancer	0.0013	0.00624	CcSEcCtD
Palonosetron—Anaemia—Fluorouracil—head and neck cancer	0.00124	0.00595	CcSEcCtD
Palonosetron—Hypersensitivity—Vinblastine—head and neck cancer	0.00123	0.0059	CcSEcCtD
Palonosetron—Body temperature increased—Hydroxyurea—head and neck cancer	0.0012	0.00577	CcSEcCtD
Palonosetron—Asthenia—Vinblastine—head and neck cancer	0.0012	0.00574	CcSEcCtD
Palonosetron—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00117	0.00562	CcSEcCtD
Palonosetron—Epistaxis—Docetaxel—head and neck cancer	0.00117	0.00561	CcSEcCtD
Palonosetron—Convulsion—Fluorouracil—head and neck cancer	0.00116	0.00558	CcSEcCtD
Palonosetron—Myalgia—Fluorouracil—head and neck cancer	0.00114	0.00548	CcSEcCtD
Palonosetron—Diarrhoea—Vinblastine—head and neck cancer	0.00114	0.00548	CcSEcCtD
Palonosetron—Discomfort—Fluorouracil—head and neck cancer	0.00113	0.00542	CcSEcCtD
Palonosetron—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00112	0.00538	CcSEcCtD
Palonosetron—Dizziness—Vinblastine—head and neck cancer	0.0011	0.00529	CcSEcCtD
Palonosetron—Urinary tract disorder—Docetaxel—head and neck cancer	0.0011	0.00527	CcSEcCtD
Palonosetron—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00109	0.00525	CcSEcCtD
Palonosetron—Connective tissue disorder—Docetaxel—head and neck cancer	0.00109	0.00525	CcSEcCtD
Palonosetron—Asthenia—Hydroxyurea—head and neck cancer	0.00109	0.00524	CcSEcCtD
Palonosetron—Urethral disorder—Docetaxel—head and neck cancer	0.00109	0.00523	CcSEcCtD
Palonosetron—Infection—Fluorouracil—head and neck cancer	0.00109	0.00522	CcSEcCtD
Palonosetron—Nervous system disorder—Fluorouracil—head and neck cancer	0.00107	0.00515	CcSEcCtD
Palonosetron—Tachycardia—Fluorouracil—head and neck cancer	0.00107	0.00513	CcSEcCtD
Palonosetron—Vomiting—Vinblastine—head and neck cancer	0.00106	0.00509	CcSEcCtD
Palonosetron—Headache—Vinblastine—head and neck cancer	0.00104	0.00501	CcSEcCtD
Palonosetron—Anorexia—Fluorouracil—head and neck cancer	0.00104	0.00501	CcSEcCtD
Palonosetron—Diarrhoea—Hydroxyurea—head and neck cancer	0.00104	0.00499	CcSEcCtD
Palonosetron—Eye disorder—Docetaxel—head and neck cancer	0.00104	0.00499	CcSEcCtD
Palonosetron—Cardiac disorder—Docetaxel—head and neck cancer	0.00103	0.00495	CcSEcCtD
Palonosetron—Hypotension—Fluorouracil—head and neck cancer	0.00102	0.00491	CcSEcCtD
Palonosetron—Angiopathy—Docetaxel—head and neck cancer	0.00101	0.00484	CcSEcCtD
Palonosetron—Dizziness—Hydroxyurea—head and neck cancer	0.001	0.00483	CcSEcCtD
Palonosetron—Immune system disorder—Docetaxel—head and neck cancer	0.001	0.00482	CcSEcCtD
Palonosetron—Mediastinal disorder—Docetaxel—head and neck cancer	0.001	0.00481	CcSEcCtD
Palonosetron—Chills—Docetaxel—head and neck cancer	0.000997	0.00479	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000996	0.00479	CcSEcCtD
Palonosetron—Arrhythmia—Docetaxel—head and neck cancer	0.000992	0.00477	CcSEcCtD
Palonosetron—Nausea—Vinblastine—head and neck cancer	0.000989	0.00475	CcSEcCtD
Palonosetron—Insomnia—Fluorouracil—head and neck cancer	0.000989	0.00475	CcSEcCtD
Palonosetron—Paraesthesia—Fluorouracil—head and neck cancer	0.000982	0.00472	CcSEcCtD
Palonosetron—Alopecia—Docetaxel—head and neck cancer	0.000982	0.00472	CcSEcCtD
Palonosetron—Dyspnoea—Fluorouracil—head and neck cancer	0.000975	0.00468	CcSEcCtD
Palonosetron—Mental disorder—Docetaxel—head and neck cancer	0.000973	0.00468	CcSEcCtD
Palonosetron—Somnolence—Fluorouracil—head and neck cancer	0.000972	0.00467	CcSEcCtD
Palonosetron—Erythema—Docetaxel—head and neck cancer	0.000967	0.00465	CcSEcCtD
Palonosetron—Malnutrition—Docetaxel—head and neck cancer	0.000967	0.00465	CcSEcCtD
Palonosetron—Vomiting—Hydroxyurea—head and neck cancer	0.000966	0.00464	CcSEcCtD
Palonosetron—Dyspepsia—Fluorouracil—head and neck cancer	0.000962	0.00463	CcSEcCtD
Palonosetron—Rash—Hydroxyurea—head and neck cancer	0.000958	0.0046	CcSEcCtD
Palonosetron—Dermatitis—Hydroxyurea—head and neck cancer	0.000957	0.0046	CcSEcCtD
Palonosetron—Headache—Hydroxyurea—head and neck cancer	0.000952	0.00457	CcSEcCtD
Palonosetron—Decreased appetite—Fluorouracil—head and neck cancer	0.00095	0.00457	CcSEcCtD
Palonosetron—Dysgeusia—Docetaxel—head and neck cancer	0.000947	0.00455	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000944	0.00454	CcSEcCtD
Palonosetron—Pain—Fluorouracil—head and neck cancer	0.000935	0.00449	CcSEcCtD
Palonosetron—Nausea—Hydroxyurea—head and neck cancer	0.000902	0.00434	CcSEcCtD
Palonosetron—Anaemia—Docetaxel—head and neck cancer	0.000894	0.0043	CcSEcCtD
Palonosetron—Body temperature increased—Fluorouracil—head and neck cancer	0.000864	0.00415	CcSEcCtD
Palonosetron—Convulsion—Docetaxel—head and neck cancer	0.000838	0.00403	CcSEcCtD
Palonosetron—Hypertension—Docetaxel—head and neck cancer	0.000835	0.00401	CcSEcCtD
Palonosetron—Myalgia—Docetaxel—head and neck cancer	0.000823	0.00396	CcSEcCtD
Palonosetron—Arthralgia—Docetaxel—head and neck cancer	0.000823	0.00396	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000818	0.00393	CcSEcCtD
Palonosetron—Hypersensitivity—Fluorouracil—head and neck cancer	0.000806	0.00387	CcSEcCtD
Palonosetron—Dry mouth—Docetaxel—head and neck cancer	0.000805	0.00387	CcSEcCtD
Palonosetron—Anaphylactic shock—Docetaxel—head and neck cancer	0.000789	0.00379	CcSEcCtD
Palonosetron—Infection—Docetaxel—head and neck cancer	0.000784	0.00377	CcSEcCtD
Palonosetron—Shock—Docetaxel—head and neck cancer	0.000776	0.00373	CcSEcCtD
Palonosetron—Nervous system disorder—Docetaxel—head and neck cancer	0.000774	0.00372	CcSEcCtD
Palonosetron—Pruritus—Fluorouracil—head and neck cancer	0.000774	0.00372	CcSEcCtD
Palonosetron—Tachycardia—Docetaxel—head and neck cancer	0.00077	0.0037	CcSEcCtD
Palonosetron—Skin disorder—Docetaxel—head and neck cancer	0.000767	0.00368	CcSEcCtD
Palonosetron—Anorexia—Docetaxel—head and neck cancer	0.000752	0.00362	CcSEcCtD
Palonosetron—Diarrhoea—Fluorouracil—head and neck cancer	0.000748	0.0036	CcSEcCtD
Palonosetron—Hypotension—Docetaxel—head and neck cancer	0.000737	0.00354	CcSEcCtD
Palonosetron—Dizziness—Fluorouracil—head and neck cancer	0.000723	0.00347	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000719	0.00346	CcSEcCtD
Palonosetron—Insomnia—Docetaxel—head and neck cancer	0.000714	0.00343	CcSEcCtD
Palonosetron—Paraesthesia—Docetaxel—head and neck cancer	0.000709	0.00341	CcSEcCtD
Palonosetron—Dyspnoea—Docetaxel—head and neck cancer	0.000704	0.00338	CcSEcCtD
Palonosetron—Somnolence—Docetaxel—head and neck cancer	0.000702	0.00337	CcSEcCtD
Palonosetron—Vomiting—Fluorouracil—head and neck cancer	0.000695	0.00334	CcSEcCtD
Palonosetron—Dyspepsia—Docetaxel—head and neck cancer	0.000695	0.00334	CcSEcCtD
Palonosetron—Rash—Fluorouracil—head and neck cancer	0.000689	0.00331	CcSEcCtD
Palonosetron—Dermatitis—Fluorouracil—head and neck cancer	0.000689	0.00331	CcSEcCtD
Palonosetron—Decreased appetite—Docetaxel—head and neck cancer	0.000686	0.0033	CcSEcCtD
Palonosetron—Headache—Fluorouracil—head and neck cancer	0.000685	0.00329	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000681	0.00327	CcSEcCtD
Palonosetron—Fatigue—Docetaxel—head and neck cancer	0.00068	0.00327	CcSEcCtD
Palonosetron—Pain—Docetaxel—head and neck cancer	0.000675	0.00324	CcSEcCtD
Palonosetron—Constipation—Docetaxel—head and neck cancer	0.000675	0.00324	CcSEcCtD
Palonosetron—Nausea—Fluorouracil—head and neck cancer	0.000649	0.00312	CcSEcCtD
Palonosetron—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000645	0.0031	CcSEcCtD
Palonosetron—Abdominal pain—Docetaxel—head and neck cancer	0.000624	0.003	CcSEcCtD
Palonosetron—Body temperature increased—Docetaxel—head and neck cancer	0.000624	0.003	CcSEcCtD
Palonosetron—Hypersensitivity—Docetaxel—head and neck cancer	0.000581	0.00279	CcSEcCtD
Palonosetron—Asthenia—Docetaxel—head and neck cancer	0.000566	0.00272	CcSEcCtD
Palonosetron—Pruritus—Docetaxel—head and neck cancer	0.000558	0.00268	CcSEcCtD
Palonosetron—Diarrhoea—Docetaxel—head and neck cancer	0.00054	0.00259	CcSEcCtD
Palonosetron—Dizziness—Docetaxel—head and neck cancer	0.000522	0.00251	CcSEcCtD
Palonosetron—Vomiting—Docetaxel—head and neck cancer	0.000502	0.00241	CcSEcCtD
Palonosetron—Rash—Docetaxel—head and neck cancer	0.000498	0.00239	CcSEcCtD
Palonosetron—Dermatitis—Docetaxel—head and neck cancer	0.000497	0.00239	CcSEcCtD
Palonosetron—Headache—Docetaxel—head and neck cancer	0.000494	0.00238	CcSEcCtD
Palonosetron—Nausea—Docetaxel—head and neck cancer	0.000469	0.00225	CcSEcCtD
